Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 17

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Reversal of Phospholamban Inhibition of the Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) Using Short, Protein-interacting RNAs and Oligonucleotide Analogs

Soller, Kailey J., Yang, Jing, Veglia, Gianluigi, Bowser, Michael T. · 2016 · Journal of Biological Chemistry

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m116.738807

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 51

  1. Bers, 2002, Cardiac excitation-contraction coupling, Nature, 415, 198, 10.1038/415198a · DOI · Paper page
  2. Bers, 2008, Calcium cycling and signaling in cardiac myocytes, Annu. Rev. Physiol, 70, 23, 10.1146/annurev.physiol.70.113006.100455 · DOI · Paper page
  3. Heidenreich, 2011, Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association, Circulation, 123, 933, 10.1161/CIR.0b013e31820a55f5 · DOI · Paper page
  4. Gwathmey, 2013, Targeting sarcoplasmic reticulum calcium ATPase by gene therapy, Hum. Gene. Ther, 24, 937, 10.1089/hum.2013.2512 · DOI
  5. Jessup, 2011, Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure, Circulation, 124, 304, 10.1161/CIRCULATIONAHA.111.022889 · DOI · Paper page
  6. Kairouz, 2012, Molecular targets in heart failure gene therapy: current controversies and translational perspectives, Ann. N. Y. Acad. Sci, 1254, 42, 10.1111/j.1749-6632.2012.06520.x · DOI
  7. Møller, 2010, The sarcoplasmic Ca2+-ATPase: design of a perfect chemi-osmotic pump, Q. Rev. Biophys, 43, 501, 10.1017/S003358351000017X · DOI · Paper page
  8. Simmerman, 1986, Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains, J. Biol. Chem, 261, 13333, 10.1016/S0021-9258(18)69309-3 · doi:10.1016/s0021-9258(18)69309-3
  9. Simmerman, 1998, Phospholamban: protein structure, mechanism of action, and role in cardiac function, Physiol. Rev, 78, 921, 10.1152/physrev.1998.78.4.921 · DOI · Paper page
  10. Tada, 1975, Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3′:5′-monophosphate-dependent protein kinase, J. Biol. Chem, 250, 2640, 10.1016/S0021-9258(19)41650-5 · DOI · Paper page
  11. Soller, 2015, Rheostatic regulation of the SERCA/phospholamban membrane protein complex using non-coding RNA and single-stranded DNA oligonucleotides, Sci. Rep, 5, 13000, 10.1038/srep13000 · DOI · Paper page
  12. Sayed, 2011, MicroRNAs in development and disease, Physiol. Rev, 91, 827, 10.1152/physrev.00006.2010 · DOI · Paper page
  13. Zhao, 2005, Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis, Nature, 436, 214, 10.1038/nature03817 · DOI · Paper page
  14. Zhao, 2007, Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1–2, Cell, 129, 303, 10.1016/j.cell.2007.03.030 · DOI · Paper page
  15. Zhou, 2014, MicroRNAs in diabetic cardiomyopathy and clinical perspectives, Front. Genet, 5, 185, 10.3389/fgene.2014.00185 · DOI
  16. Bao, 2013, Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells, Int. J. Mol. Sci, 14, 23086, 10.3390/ijms141123086 · DOI · Paper page
  17. Mishra, 2009, MicroRNAs as a therapeutic target for cardiovascular diseases, J. Cell. Mol. Med, 13, 778, 10.1111/j.1582-4934.2009.00744.x · DOI
  18. Tijsen, 2012, Non-cardiomyocyte microRNAs in heart failure, Cardiovasc. Res, 93, 573, 10.1093/cvr/cvr344 · DOI
  19. Wijnen, 2014, Cardiomyocyte-specific miRNA-30c over-expression causes dilated cardiomyopathy, PLoS One, 9, e96290, 10.1371/journal.pone.0096290 · DOI
  20. Mishra, 2013, Cardiac matrix: a clue for future therapy, Biochim. Biophys. Acta, 1832, 2271, 10.1016/j.bbadis.2013.09.004 · DOI
  21. Halkein, 2013, MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy, J. Clin. Invest, 123, 2143, 10.1172/JCI64365 · DOI · Paper page
  22. Keklikoglou, 2015, MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes, Oncogene, 34, 4867, 10.1038/onc.2014.408 · DOI
  23. Madden, 1979, Cholesterol modulates activity of calcium-dependent ATPase of the sarcoplasmic reticulum, Nature, 279, 538, 10.1038/279538a0 · DOI
  24. Gustavsson, 2011, Activating and deactivating roles of lipid bilayers on the Ca2+-ATPase/phospholamban complex, Biochemistry, 50, 10367, 10.1021/bi200759y · DOI · Paper page
  25. Datta, 2003, Salt dependence of DNA binding by Thermus aquaticus and Escherichia coli DNA polymerases, J. Biol. Chem, 278, 5694, 10.1074/jbc.M208133200 · DOI
  26. Datta, 2003, Thermodynamics of the binding of Thermus aquaticus DNA polymerase to primed-template DNA, Nucleic Acids Res, 31, 5590, 10.1093/nar/gkg774 · doi:10.1093/nar/gkg774
  27. Eom, 1996, Structure of Taq polymerase with DNA at the polymerase active site, Nature, 382, 278, 10.1038/382278a0 · DOI · Paper page
  28. Gottesfeld, 2001, Energetics and affinity of the histone octamer for defined DNA sequences, Biochemistry, 40, 10927, 10.1021/bi0109966 · DOI
  29. Luger, 1997, Crystal structure of the nucleosome core particle at 2.8 Å resolution, Nature, 389, 251, 10.1038/38444 · DOI · Paper page
  30. van Rooij, 2012, MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles, Nat. Rev. Drug Discov, 11, 860, 10.1038/nrd3864 · DOI · Paper page
  31. Bers, 2000, Calcium fluxes involved in control of cardiac myocyte contraction, Circ. Res, 87, 275, 10.1161/01.RES.87.4.275 · DOI · Paper page
  32. Cornea, 2013, High-throughput FRET assay yields allosteric SERCA activators, J. Biomol. Screen, 18, 97, 10.1177/1087057112456878 · DOI
  33. Gruber, 2014, Discovery of enzyme modulators via high-throughput time-resolved FRET in living cells, J. Biomol. Screen, 19, 215, 10.1177/1087057113510740 · DOI
  34. Li, 1998, Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects, Am. J. Physiol, 274, H1335
  35. Ha, 2011, Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A, Proc. Natl. Acad. Sci. U.S.A, 108, 2735, 10.1073/pnas.1013987108 · DOI
  36. Vostrikov, 2015, Effects of naturally occurring arginine 14 deletion on phospholamban conformational dynamics and membrane interactions, Biochim. Biophys. Acta, 1848, 315, 10.1016/j.bbamem.2014.09.007 · DOI
  37. Ceholski, 2012, Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy, J. Biol. Chem, 287, 16521, 10.1074/jbc.M112.360859 · DOI · Paper page
  38. Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proc. Natl. Acad. Sci. U.S.A, 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
  39. van der Zwaag, 2012, Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy, Eur. J. Heart Fail, 14, 1199, 10.1093/eurjhf/hfs119 · DOI · Paper page
  40. Bai, 2013, Phospholamban knockout breaks arrhythmogenic Ca2+ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice, Circ. Res, 113, 517, 10.1161/CIRCRESAHA.113.301678 · doi:10.1161/circresaha.113.301678
  41. Cornea, 1997, Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers, Biochemistry, 36, 2960, 10.1021/bi961955q · DOI · Paper page
  42. Ha, 2007, Controlling the inhibition of the sarcoplasmic Ca2+-ATPase by tuning phospholamban structural dynamics, J. Biol. Chem, 282, 37205, 10.1074/jbc.M704056200 · DOI
  43. Ha, 2012, Tuning the structural coupling between the transmembrane and cytoplasmic domains of phospholamban to control sarcoplasmic reticulum Ca2+-ATPase (SERCA) function, J. Muscle Res. Cell Motil, 33, 485, 10.1007/s10974-012-9319-4 · DOI
  44. Größl, 2014, A novel artificial microRNA expressing AAV vector for phospholamban silencing in cardiomyocytes improves Ca2+ uptake into the sarcoplasmic reticulum, PLoS One, 9, e92188, 10.1371/journal.pone.0092188 · DOI
  45. Cheng, 2007, MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hypertrophy?, Am. J. Pathol, 170, 1831, 10.2353/ajpath.2007.061170 · DOI · Paper page
  46. Tatsuguchi, 2007, Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy, J. Mol. Cell. Cardiol, 42, 1137, 10.1016/j.yjmcc.2007.04.004 · DOI · Paper page
  47. Li, 2010, Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy, J. Cell Sci, 123, 2444, 10.1242/jcs.067165 · DOI
  48. Buck, 2003, Overexpression, purification, and characterization of recombinant Ca-ATPase regulators for high-resolution solution and solid-state NMR studies, Protein Expr. Purif, 30, 253, 10.1016/S1046-5928(03)00127-X · DOI · Paper page
  49. Stokes, 1990, Three-dimensional crystals of CaATPase from sarcoplasmic reticulum. Symmetry and molecular packing, Biophys. J, 57, 1, 10.1016/S0006-3495(90)82501-7 · DOI
  50. Shackman, 2004, High-throughput automated post-processing of separation data, J. Chromatogr. A, 1040, 273, 10.1016/j.chroma.2004.04.004 · doi:10.1016/j.chroma.2004.04.004
  51. Jing, 2011, Methods for measuring aptamer-protein equilibria: a review, Anal. Chim. Acta, 686, 9, 10.1016/j.aca.2010.10.032 · DOI · Paper page

Cited by

See all 17

Metadata

Authors
Soller, K. J., Yang, J., Veglia, G., & Bowser, M. T.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2016-10
Volume
291
Issue
41
Pages
21510-21518
ISSN
0021-9258
Cited by
17
References
1
Language
en
Licence
Funders
  • National Institutes of Health (GM063533, GM072701)
  • American Heart Association (13PRE16950023)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reversal of Phospholamban Inhibition of the Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) Using Short, Protein-interacting RNAs and Oligonucleotide Analogs. https://app.cochat.ai/papers/10.1074/jbc.m116.738807
The paper
Soller, K. J., Yang, J., Veglia, G., & Bowser, M. T. (2016). Reversal of Phospholamban Inhibition of the Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) Using Short, Protein-interacting RNAs and Oligonucleotide Analogs. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m116.738807

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.